Welcome and Keynote Session: Strategies for Successful Mass Vaccination Rollout: Balancing Science, Politics, Communication and Trust [Plenary]

Meet the other ICPE delegates in an informal setting – the ideal place to put a face to the name of the one you've been emailing throughout the pandemic! Make new plans with friends and colleagues for your time in Copenhagen. Light finger food and drinks will be served.

Click the breakout session you would like to attend below:

• Data Harmonization, Standardization, and Quality Assessment in Distributed Health Data Networks: Lessons from Around the World
• Post-authorization Regulatory Strategies to Evaluate Drug Safety in Pregnancy: How to Optimize the Design of Registries & Database Studies
• Representing and Leveraging Heterogeneity Between Data Sources in Multi-database Pharmacoepidemiologic Studies
• Methodological Challenges in Assessing the Impact of Digital Technologies on Patient Adherence
• Using Real-World Data and Pharmacoepidemiologic Methods to Advance the Science of Deprescribing Research

Click the breakout session you would like to attend below:

• A Tivoli Gardens Distillery of Applied Methods
• Antidiabetics - Not Just About Diabetes
• From Motherhood to Childhood, Moody to Healthy
• Challenges in Healthy Aging
• Moving from Trials to Real-World Evidence, Back and Forth
• Medicating for Two: Pregnancy, Maternal, and Infant Outcomes

Click the breakout session you would like to attend below:

• Considerations of Misclassification and Confounding on COVID-19 Vaccines Effectiveness Studies - A Vaccine SIG Endorsed Symposium
• Advanced Methods for Covariate Balancing: Going Beyond Propensity Score Matching and Weighting Using Optimization Techniques
• Methods and Considerations for Hypothesis-free Signal Detection Studies Accommodating Various Types of Medications, Populations, and Regions
• Meeting the Need for Research on Drug Safety During Lactation: An Overview of Approaches
• It Takes a Village: Strategic Global Collaborations to Advance RWE Within ISPE

Click the breakout session you would like to attend below:

• Pharmacoepidemiologic Methods and SARS-CoV-2
• Drug Utilization Studies in Cardiovascular Disease and Diabetes
• Pediatric Medicine Use: Safe Kids in an Uncertain Landscape
• Smörgåsbord
• Lightning Session 1
• Methods - Comparators, Controls, and Unmeasured Confounding

Click the breakout session you would like to attend below:

• Drug Utilization Potpourri
• Opioids and Addiction - The Other Pandemic?
• Across the Globe: Injury and Neurologic Pharmacoepidemiology
• Safety First!
• Disease Epidemiology Potpourri
• Methods for Generating RWE Through Emulation of Target Trials

Updates from the COVID-19 Pharmacoepidemiological Battlefield: Recent Victories and Battles Ahead [Plenary]

In this session, our four esteemed speakers will both look back over the many contributions from the pharmacoepidemiological society to the handling of the COVID-19 pandemic, as well as outline both learnings and likely challenges that lies ahead. Specifically, we will discuss the value of coordinated global collaborations in addressing urgent safety issues, what methodological insights we should take from these recent years, what regulators have learned and will expect from the pharmacoepidemiological society in the future, and what areas of the pandemic that will likely provide the study questions of the future.

Click the breakout session you would like to attend below:

• Methods: Machines Making Predictions
• Study Design Approaches to Assessing Thrombosis Risk
• What's the Risk? Cancer Risk & Common Medications
• Psychotropic Use Around the World
• Mending Hearts and Brains
• Lightning Session 2

Call to Order & President's Address

Vin Lo Re, FISPE, ISPE President

Financial Report

Wei Zhou, FISPE, Vice President/Finance

New Business

Awards Ceremony

ISPE Board Transition

Click the breakout session you would like to attend below:

• Cloning, Censoring, and Weighting — Oh My!
• COVID-19 Vaccine Safety Monitoring: Opportunities, Challenges and Lessons Learned for Pharmacoepidemiology
• Drug Safety on the Cutting Edge: What are the Implications of EMA's To-Be-Released Risk Minimisation Guidance
• Real-World Evidence Studies in the post-COVID-19 Era: Methodological Considerations for Pandemic Related Disruptions
• Late Breakers
• HARmonized Protocol to Enhance Reproducibility (HARPER): An ISPE-ISPOR Joint Task Force of the RWE Initiative

Click the breakout session you would like to attend below:

• Pandemic Prescription Patterns (Plus Pneumonia!)
• Examining Equity: Who? Where and What?
• Concurrent Oral Sessions
• Around the World With Real-World Evidence
• SGLT2s and Cardiovascular Endpoints
• Welcoming Novel Methods in Pregnancy Research

Click the breakout session you would like to attend below:

• What Do Real World Data Validation Best Practices Look Like?
• Updating the Public on COVID-19 Vaccine Safety - Considerations for Pharmacoepidemiologists
• Emulation Differences versus Bias: Implications of Large-scale Emulation of Randomized Clinical Trials Using Clinical Practice Data
• COVID-19 Vaccine Use During Pregnancy: Accelerating Innovative Evidence Generation Platforms to Meet Current and Future Challenges
• Shaping the Future of Pharmacoepidemiology

Click the breakout session you would like to attend below:

• Fractures and Osteoporosis Medication
• Use it or Lose Out: Trends in Anti-Cancer and Biologic Utilization
• Safety Issues Concerning DM and Antidiabetic Drugs
• Evaluating the Vaccines Against the Nasty Bugs: Safety First Round II
• Lightning Session 3
• Novel Approaches to Pharmacovigilance

Description

The symposium will start with 5 presentations (10-12 min each) on the topic followed by a panel discussion.

Overview

1. The big sick: the rise of data-driven versus design-driven RWE studies and research waste (A Winterstein)
2. The big cure 1: how can we mitigate publication of poorly conducted RWE studies – training non-pharmacoepidemiologists in good p-epi practice (T Stuermer)
3. The big cure 2: a priori study protocols, author and reviewer expertise (M Smith)
4. The big cure Part 3: checklists and guidances (V Ehrenstein)
5. The big cure Part 4: Data provenance and custodianship (J Brown)

AGENDA

38th ICPE Awards

Spotlight Poster Awards

2023 Meetings:

• Mid-Year Meeting, Reykjavik, Iceland Helga Gardarsdottir, Chair, Mid-year Program Planning Committee
• 39th ICPE, Halifax, Nova Scotia, Canada Robert Platt, Chair, Scientific Program Committee

Adjournment of the ICPE 2022